AIML AI/ML Innovations Inc.
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers The Neural Cloud, a signal processing neural network designed to extract true signals from the noisiest recordings; Cardio Yield, an ECG reporting software, built to automate event labeling, interval calculation, and rhythm classification; and Insight 360 that transforms raw ECG data into clear, actionable insights through advanced visualization, analytics, and customizable reporting tools. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is based in Vancouver, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About AI/ML Innovations (CNSX: AIML)
›
AI/ML Innovations (CNSX: AIML) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.0450 CAD on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0300 CAD to 0.0850 CAD: the price is 47.1% below the high and 50.0% above the low.
Its market capitalisation is 13.43M CAD.
AI/ML Innovations reports revenue down 95.2% year over year.
Its debt exceeds its cash by 2.38M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.